Sarepta Therapeutics | 4:持股变动声明-董事 BEHRENS M KATHLEEN
Sarepta Therapeutics | 4:持股变动声明-高管 Brown Ryan Edward
Sarepta Therapeutics | 4:持股变动声明-高管 Rodino-Klapac Louise
Sarepta Therapeutics | 4:持股变动声明-高管 Murray Dallan
Sarepta Therapeutics | 4:持股变动声明-高管 Estepan Ian Michael
Sarepta Therapeutics | 4:持股变动声明-高管 Arif Bilal
Sarepta Therapeutics | 144:拟议出售证券
Sarepta Therapeutics | 144:拟议出售证券
Sarepta Therapeutics | 144:拟议出售证券
Sarepta Therapeutics | 8-K:重大事件
Sarepta Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(10.7%)
Sarepta Therapeutics | 4:持股变动声明-高管 Murray Dallan
Sarepta Therapeutics | 3:首次持股声明-高管 Murray Dallan
Sarepta Therapeutics | 10-Q:季度报表
Sarepta Therapeutics | DEF 14A:股东委托书决议
Sarepta Therapeutics | ARS:年度报告
Sarepta Therapeutics | DEFA14A:其他
Sarepta Therapeutics | S-8 POS:员工福利计划证券登记(修正)
Sarepta Therapeutics | S-8 POS:员工福利计划证券登记(修正)
Sarepta Therapeutics | S-8 POS:员工福利计划证券登记(修正)
暂无数据